ClinicalTrials.Veeva

Menu

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

Zimmer Biomet logo

Zimmer Biomet

Status

Completed

Conditions

Osteoarthritis
Avascular Necrosis

Treatments

Device: Oxford® Meniscal Unicompartmental Knee System

Study type

Observational

Funder types

Industry

Identifiers

NCT00578994
P010014 (Other Identifier)
ORTHO.CR.K016

Details and patient eligibility

About

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in the United States.

Full description

Study Objective

To provide a prospective 2-year post-operative evaluation of complications and 9-year long-term survivorship analysis of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in the United States.

Study Design

The study is designed as a prospective, multi-center, non-randomized post approval study. There are two phases to this study:

  1. A complications study where patients will be followed for at least 2 years to record all complications that may occur, and
  2. A survival study that will record at yearly intervals out to 9 years whether or not the device is still in place or if it has been removed for any reason.

Phase 1 requires clinical follow-up (0-2 year) and patients will be evaluated at pre-defined intervals up to 2 years post-operative. Information gathered in phase 1 includes all adverse events and survival data.

Phase 2 (3-9 year) only gathers survival data through patient directed mailing and/or phone call.

Enrollment

388 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with one of the following diagnoses in the medial compartment of the knee: Osteoarthritis, Avascular Necrosis

Exclusion criteria

  • Patients with Rheumatoid arthritis or other forms of inflammatory joint disease
  • Patients with infection, sepsis, and osteomyelitis
  • Patients with Osteoporosis, Paget's Disease, Charcot's disease, Osteomalacia, and Severe Osteoporosis

Trial design

388 participants in 1 patient group

Oxford® Meniscal Unicompartmental Knee
Description:
Patients with PKA using the Oxford® Meniscal Unicompartmental Knee System
Treatment:
Device: Oxford® Meniscal Unicompartmental Knee System

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems